Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2010 Aug 4:(8):CD007701.
doi: 10.1002/14651858.CD007701.pub2.

Different methods for the induction of labour in outpatient settings

Affiliations
Meta-Analysis

Different methods for the induction of labour in outpatient settings

Therese Dowswell et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: Induction of labour is carried out for a variety of indications and using a range of pharmacological, mechanical and other methods. For women at low risk, some methods of induction of labour may be suitable for use in outpatient settings.

Objectives: To examine pharmacological and mechanical interventions to induce labour in outpatient settings in terms of feasibility, effectiveness, maternal satisfaction, healthcare costs and, where information is available, safety. The review complements existing reviews on labour induction examining effectiveness and safety.

Search strategy: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (December 2009) and reference lists of retrieved studies.

Selection criteria: We included randomised controlled trials examining outpatient cervical ripening or induction of labour with pharmacological agents or mechanical methods.

Data collection and analysis: Two authors independently extracted data and assessed eligible papers for risk of bias. We checked all data after entry into review manager software.

Main results: We included 28 studies with 2616 women examining different methods of induction of labour where women received treatment at home or were sent home after initial treatment and monitoring in hospital.Studies examined vaginal and intracervical PGE(2), vaginal and oral misoprostol, isosorbide mononitrate, mifepristone, oestrogens, and acupuncture. Overall, the results demonstrate that outpatient induction of labour is feasible and that important adverse events are rare. There was no strong evidence that agents used to induce labour in outpatient settings had an impact (positive or negative) on maternal or neonatal health. There was some evidence that, compared to placebo or no treatment, induction agents reduced the need for further interventions to induce labour, and shortened the interval from intervention to birth. We were unable to pool results on outcomes relating to progress in labour as studies tended to measure a very broad range of outcomes.There was no evidence that induction agents increased interventions in labour such as operative deliveries. Only two studies provided information on women's views about the induction process, and overall there was very little information on the costs to health service providers of different methods of labour induction in outpatient settings.

Authors' conclusions: Induction of labour in outpatient settings appears feasible. We do not have sufficient evidence to know which induction methods are preferred by women, or the interventions that are most effective and safe to use in outpatient settings.

PubMed Disclaimer

Similar articles

Cited by

References

References to studies included in this review

    1. Bollapragada S, Mackenzie F, Norrie J, Petrou S, Reid M, Greer I, et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth. 2006;6:25. - PMC - PubMed
    2. Bollapragada SS, MacKenzie F, Norrie J, Petrou S, Reid M, Greer IA, et al. Randomized placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability. The IMOP study [abstract] Journal of Obstetrics and Gynaecology. 2007;27(Suppl 1):S22. - PubMed
    3. Bollapragada SS, MacKenzie F, Norrie JD, Eddama O, Petrou S, Reid M, et al. Randomised placebo-controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour-clinical trial with analyses of efficacy and acceptability. The IMOP study. BJOG: an international journal of obstetrics and gynaecology. 2009;116(9):1185–95. - PubMed
    4. Eddama O, Petrou S, Schroeder L, Bollapragada SS, Mackenzie F, Norrie J, et al. The cost-effectiveness of outpatient (at home) cervical ripening with isosorbide mononitrate prior to induction of labour. BJOG: an international journal of obstetrics and gynaecology. 2009;116(9):1196–203. - PubMed
    1. Bullarbo M, Orrskog ME, Andersch B, Granstrom L, Norstrom A, Ekerhovd E. Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. American Journal of Obstetrics & Gynecology. 2007;196(1):50.e1–50.e5. - PubMed
    1. Buttino LTCL, Garite TJ. Intracervical prostaglandin in postdate pregnancy. A randomized trial. Journal of Reproductive Medicine. 1990;35:155–8. - PubMed
    1. Elliot CL, Brennand JE, Calder AA. The effect of mifepristone (RU486) on cervical ripening and induction of labour in human pregnancy. 27th British Congress of Obstetrics and Gynaecology; Dublin, Ireland. 1995 July 4-7.1995. p. 207.
    2. Elliott CL, Brennand JE, Calder AA. The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstetrics & Gynecology. 1998;92(5):804–9. - PubMed
    1. Frydman R, Baton C, Lelaidier C, Vial M, Bourget P, Fernandez H. Mifepristone for induction of labour. Lancet. 1991;337:488–9. - PubMed
    2. Frydman R, Lelaidier C, Baton-Saint-Mleux C, Fernandez H, Vial M, Bourget P. Labor induction in women at term with mifepristone (RU 486): a double blind, randomized, placebo-controlled study. Obstetrics & Gynecology. 1992;80:972–5. - PubMed
    3. Frydman R, Lelaidier C, Baton-Saint-Mleux C, Fernandez H, Vial M, Bourget P. Labor induction in women at term with mifepristone (RU 486): a double-blind, randomized, placebo-controlled study. International Journal of Gynecology & Obstetrics. 1993;42(2):220. - PubMed
    4. Frydman R, Taylor S, Paoli C, Pourade A. Ru 486 (mifepristone): A new tool for labour induction in term women with fetus alive [Le RU 486 (mifepristone) un novel outil pour le declenchment du travail a terme] Contraception, Fertilite, Sexualite. 1992;20(12):1133–6. - PubMed
    5. Lelaidier C, Benifla JL, Fernandez H, Baton C, Bourget P, Bourrier MC, et al. RU 486 (mifepristone) in medical indications for labour induction in pregnancies at term: results of a randomized, double-blind study of RU 486 vs placebo. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction. 1993;22:92–100. - PubMed

References to studies excluded from this review

    1. Adewole IF, Franklin O, Matiluko AA. Cervical ripening and induction of labour by breast stimulation. African Journal of Medicine and Medical Sciences. 1993;22:81–6. - PubMed
    1. Damania KR, Nanavati MS, Dastur NA, Daftary SN. Breast stimulation for cervical ripening. Journal of Obstetrics and Gynaecology of India. 1988;58:663–5.
    1. Damania KK, Natu U, Mhatre PN, Mataliya M, Mehta AC, Daftary SN. Evaluation of two methods employed for cervical ripening. Journal of Postgraduate Medicine. 1992;38(2):58–9. - PubMed
    1. Di Lieto A, Miranda L, Ardito P, Favale P, Albano G. Changes in the bishop score induced by manual nipple stimulation. A cross-over randomized study. Clinical and Experimental Obstetrics and Gynecology. 1989;16:26–9. - PubMed
    1. Doany W. Outpatient management of postdate pregnancy with intravaginal prostaglandin E2 and membrane stripping. American Journal of Obstetrics and Gynecology. 1996;174(1Pt 2):351.
    2. Doany W, McCarty J. Outpatient management of the uncomplicated postdate pregnancy with intravaginal prostaglandin E2 gel and membrane stripping. Journal of Maternal-Fetal Medicine. 1997;6(2):71–8. - PubMed

References to studies awaiting assessment

    1. Ascher-Walsh C, Burke B, Baxi L. Outpatient management of prolonged pregnancy with misoprostol (mp): a randomized double-blind placebo controlled study, prelim data. American Journal of Obstetrics and Gynecology. 2000;182(1 Pt 2):S20.
    1. Thakur V, Dorman E, Sanu L, Harrington K. Mifepristone is an effective ripening agent in postdates primips with cervical length >= 2.5cm, but mode of delivery correlates with birthweight: a randomised, placebo controlled double blind study. Ultrasound in Obstetrics and Gynecology. 2005;26:452.

Additional references

    1. Alfirevic Z, Weeks A. Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews. 2006;(Issue 2) [DOI: 10.1002/14651858.CD001338.pub2] - PubMed
    1. Bollapragada S, Mackenzie F, Norrie J, Petrou S, Reid M, Greer I, et al. IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy and Childbirth. 2006;6:25. - PMC - PubMed
    1. Boulvain M, Kelly AJ, Irion O. Intracervical prostaglandins for induction of labour. Cochrane Database of Systematic Reviews. 2008;(Issue 1) [DOI: 10.1002/14651858.CD006971] - PubMed
    1. Curtis P, Evans S, Resnick J. Uterine hyperstimulation. The need for standard terminology. Journal of Reproductive Medicine. 1987;32:91–5. - PubMed
    1. Elliott JP, Clewell WH, Radin TG. Intracervical prostaglandin E2 gel. Safety for outpatient cervical ripening before induction of labor. Journal of Reproductive Medicine. 1992;37(8):713–6. - PubMed

LinkOut - more resources